Finance

Lists
CHRS:NASDAQ
Coherus Oncology Inc
$ 1.18
+1.72%
(+0.020) 1D
10-р сарын 2, 10:46:37 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Open
$ 1.19
High
$ 1.19
Low
$ 1.16
Mkt. cap
182.31 сая
Avg. vol.
1.22 сая
Volume
125.88 мян
52-wk high
$ 2.62
52-wk low
$ 1.09
EPS
-$ 1.03
Beta
0.98
Shares outstanding
154.50 сая
No. of employees
144
Open
$ 1.19
High
$ 1.19
Low
$ 1.16
Mkt. cap
182.31 сая
Avg. vol.
1.22 сая
Volume
125.88 мян
52-wk high
$ 2.62
52-wk low
$ 1.09
EPS
-$ 1.03
Beta
0.98
Shares outstanding
154.50 сая
No. of employees
144
News stories
From web sources and news partners
About Coherus Oncology Inc
CEODennis Lanfear
Employees144
Founded2010
HeadquartersRedwood City, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to CHRS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CHRS in the last 3 months.
Highest
Current $ 1.18
$ 10.00 (+747.46%)
Average
$ 7.75 (+556.78%)
Lowest
$ 4.00 (+238.98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$ 7.00
+493.2%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$ 4.00
+239%
08/06/2026
Paul Jeng
Guggenheim
Buy
Maintained
$ 10.00
+747.5%
08/06/2026
Jay Olson
Oppenheimer
Buy
Maintained
$ 10.00
+747.5%
08/06/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
-
-
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
11.57 сая
12.75 сая
12.31 сая
14.31 сая
Cost of goods sold
3.72 сая
4.04 сая
3.81 сая
4.24 сая
Cost of revenue
3.72 сая
4.04 сая
3.81 сая
4.24 сая
Research and development expenses
27.25 сая
30.97 сая
21.54 сая
21.45 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.83 сая
21.01 сая
23.10 сая
20.95 сая
Operating expense
50.08 сая
51.98 сая
44.65 сая
42.40 сая
Total operating expenses
53.80 сая
56.03 сая
48.46 сая
46.64 сая
Operating income
-42.23 сая
-43.28 сая
-36.15 сая
-32.33 сая
Other non operating income
2.14 сая
-5.22 сая
1.40 сая
1.31 сая
EBT including unusual items
-44.52 сая
-46.35 сая
-36.94 сая
-33.35 сая
EBT excluding unusual items
-42.42 сая
-43.75 сая
-36.94 сая
-33.35 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-35.53 сая
-37.64 сая
-38.33 сая
-20.63 сая
Net profit margin
-307.07%
-295.29%
-311.35%
-144.20%
Earnings per share
-0.33
-0.34
-0.25
-0.19
Interest and investment income
-
7.00 сая
-
-
Interest expense
-2.32 сая
-2.25 сая
-2.19 сая
-2.32 сая
Net interest expenses
-2.32 сая
4.75 сая
-2.19 сая
-2.32 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.27 сая
-42.38 сая
-35.27 сая
-31.47 сая
Gain or loss from assets sale
-
-338.32 сая
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс